Market by Product, Application, Industry Verticals, and Country | Forecast 2021-2028
Triton’s
report implies that the Latin American CRISPR market is expected to surge at a
compound annual growth rate of 18.82% during the predicted period 2021-2028.
Report scope can be customized per your requirements. Request For Customization
The
countries scrutinized in this market include:
• Brazil
• Mexico
• Rest of Latin America
In
the region, farmers are partnering with scientists to create new crop varieties
using gene-editing techniques like CRISPR-Cas9. This step is to help the region
realize its potential in the food production industry. Moreover, these
partnerships are the extension of the work performed by farmers over the years.
Moreover, the new research is focused mainly on countries that are open to
adopting gene-editing technologies. However, the region gains a small
percentage of the CRISPR market due to a lack of technological development.
Nevertheless, the steady growth in gene-editing is likely to create
opportunities for the CRISPR market.
Among
the countries, Brazil dominates the CRISPR market, with researchers
contributing to the majority of the growth. For instance, the phylogenetic
analysis of the Brazilian genome showed that the strains share a larger number
of SNPs than other ST277 genomes. Additionally, the Brazilian endemic clone
pseudomonas aeruginosa ST277 contains vital antibiotic resistance determinants,
emphasizing the gene coding for SPM-1. Thus, as mentioned above, these factors
are expected to support the development of the CRISPR market across Brazil in
the upcoming years.
CRISPR
Therapeutics AG is a gene-editing company engaged in the development of
transformative gene-based medicines to treat various chronic conditions. Its
product line includes CTX001, an autologous CRISPR gene-edited hematopoietic
stem cell therapy for ?-thalassemia and
sickle cell disease patients. Additionally, the company offers solutions
relating to hemoglobinopathies, immuno-oncology, regenerative medicine, and
In-vivo. CRISPR Therapeutics offers products across multiple regions, including
Latin America.
Market By Type, Application, E ..
VIEW REPORT
Market By Device Type, Therape ..
VIEW REPORT
Market By Type, Application, T ..
VIEW REPORT
Market By Technology, Applicat ..
VIEW REPORT
Market By Application, Type, E ..
VIEW REPORT
Market by Therapeutics, Diagno ..
VIEW REPORT
Market by Type, Application, E ..
VIEW REPORT1. LATIN
AMERICA CRISPR MARKET - SUMMARY
2. INDUSTRY
OUTLOOK
2.1. IMPACT
OF COVID-19 ON CRISPR MARKET
2.2. KEY
INSIGHTS
2.2.1. INDUSTRIAL
BIOTECH IS THE FASTEST GROWING INDUSTRY VERTICAL
2.2.2. REWRITING
OF GENETIC DISORDERS THROUGH GENOME SURGERY
2.2.3. INCREASING
USAGE OF PROSPECTIVE APPLICATIONS OF CRISPR TECHNOLOGY
2.3. PORTER’S
FIVE FORCES ANALYSIS
2.3.1. THREAT
OF NEW ENTRANTS
2.3.2. THREAT
OF SUBSTITUTES
2.3.3. BARGAINING
POWER OF BUYERS
2.3.4. BARGAINING
POWER OF SUPPLIERS
2.3.5. THREAT
OF COMPETITIVE RIVALRY
2.4. MARKET
ATTRACTIVENESS INDEX
2.5. VENDOR
SCORECARD
2.6. LEGAL
& REGULATORY OUTLOOK
2.7. PATENT
OUTLOOK
2.8. FUNDING
OUTLOOK
2.9. KEY
IMPACT ANALYSIS
2.9.1. COST
2.9.2. ACCURACY
2.9.3. EASY
TO USE
2.10. KEY
MARKET STRATEGIES
2.10.1. ACQUISITIONS
2.10.2. PRODUCT
LAUNCHES
2.10.3. CONTRACTS
& PARTNERSHIPS
2.10.4. BUSINESS
EXPANSIONS & DIVESTITURES
2.11. MARKET
DRIVERS
2.11.1. GROWING
LIFESTYLE-ORIENTED DISEASES
2.11.2. SURGING
PREVALENCE OF GENETIC DISEASES
2.12. MARKET
CHALLENGES
2.12.1. GROWING
ETHICAL ISSUES REGARDING TECHNOLOGY USE
2.12.2. LIKELY
MISUSE OF GENE-EDITING TOOL
2.12.3. ABSENCE
OF HEALTHCARE BUDGETS IN DEVELOPING COUNTRIES
2.13. MARKET
OPPORTUNITIES
2.13.1. ADVANCEMENTS
IN GENE-BASED THERAPY IN THE AGRICULTURAL SECTOR
2.13.2. INCREASED
NEED FOR CLINICAL TRIALS
2.13.3. RISE
IN AWARENESS ABOUT GENE THERAPEUTICS
3. LATIN
AMERICA CRISPR MARKET OUTLOOK - BY PRODUCT
3.1. PLASMIDS
3.2. VECTORS
3.3. PROTEINS
3.4. DESIGNING
TOOLS
3.5. GRNA
3.6. CONTROL
KITS
3.7. LIBRARY
3.8. OTHER
PRODUCTS
4. LATIN
AMERICA CRISPR MARKET OUTLOOK - BY APPLICATION
4.1. GENOME
EDITING/GENETIC ENGINEERING
4.2. CRISPR
PLASMID
4.3. HUMAN
STEM CELLS
4.4. GRNA
DATABASE/GENE LIBRARY
4.5. CELL
LINE ENGINEERING
5. LATIN
AMERICA CRISPR MARKET OUTLOOK - BY INDUSTRY VERTICALS
5.1. THERAPEUTICS
AND DRUG DISCOVERY
5.2. BIOLOGICAL
RESEARCH
5.3. AGRICULTURAL
BIOTECH
5.4. INDUSTRIAL
BIOTECH
6. LATIN
AMERICA CRISPR MARKET – REGIONAL OUTLOOK
6.1. BRAZIL
6.2. MEXICO
6.3. REST
OF LATIN AMERICA
7. COMPETITIVE
LANDSCAPE
7.1. ADDGENE
7.2. CARIBOU
BIOSCIENCES INC
7.3. CELLECTIS
BIORESEARCH SAS
7.4. CRISPR
THERAPEUTICS AG
7.5. EDITAS
MEDICINE
7.6. GENSCRIPT
7.7. HORIZON
DISCOVERY GROUP
7.8. INTEGRATED
DNA TECHNOLOGIES
7.9. INTELLIA
THERAPEUTICS
7.10. LONZA
GROUP LTD
7.11. NEW
ENGLAND BIOLABS
7.12. NOVARTIS
INTERNATIONAL AG
7.13. ORIGENE
TECHNOLOGIES INC
7.14. PRECISION
BIOSCIENCES
7.15. SYNTHEGO
CORPORATION
8. RESEARCH
METHODOLOGY & SCOPE
8.1. RESEARCH
SCOPE & DELIVERABLES
8.2. SOURCES
OF DATA
8.3. RESEARCH
METHODOLOGY
TABLE 1: LATIN AMERICA CRISPR
MARKET, BY COUNTRY, 2021-2028 (IN $ MILLION)
TABLE 2: VENDOR SCORECARD
TABLE 3: REGULATORY FRAMEWORK
TABLE 4: FUNDING OUTLOOK OF
PUBLIC COMPANIES
TABLE 5: FUNDING OUTLOOK OF
PRIVATE COMPANIES
TABLE 6: FUNDING OUTLOOK OF
GOVERNMENT ORGANIZATIONS
TABLE 7: LATIN AMERICA CRISPR
MARKET, BY PRODUCT, 2021-2028 (IN $ MILLION)
TABLE 8: LATIN AMERICA CRISPR
MARKET, BY APPLICATION, 2021-2028 (IN $ MILLION)
TABLE 9: LATIN AMERICA CRISPR
MARKET, BY INDUSTRY VERTICALS, 2021-2028 (IN $ MILLION)
TABLE 10: LATIN AMERICA CRISPR
MARKET, BY COUNTRY, 2021-2028 (IN $ MILLION)
FIGURE 1: MARKET
ATTRACTIVENESS INDEX
FIGURE 2: FUNDING SCENARIO
SHARE, BY TYPE OF COMPANIES/ORGANIZATION
FIGURE 3: KEY IMPACT ANALYSIS
FIGURE 4: LATIN AMERICA CRISPR
MARKET, BY PRODUCT, 2020 & 2028 (IN %)
FIGURE 5: LATIN AMERICA CRISPR
MARKET, BY PLASMIDS, 2021-2028 (IN $ MILLION)
FIGURE 6: LATIN AMERICA CRISPR
MARKET, BY VECTORS, 2021-2028 (IN $ MILLION)
FIGURE 7: LATIN AMERICA CRISPR
MARKET, BY PROTEINS, 2021-2028 (IN $ MILLION)
FIGURE 8: LATIN AMERICA CRISPR
MARKET, BY DESIGNING TOOLS, 2021-2028 (IN $ MILLION)
FIGURE 9: LATIN AMERICA CRISPR
MARKET, BY GRNA, 2021-2028 (IN $ MILLION)
FIGURE 10: LATIN AMERICA
CRISPR MARKET, BY CONTROL KITS, 2021-2028 (IN $ MILLION)
FIGURE 11: LATIN AMERICA
CRISPR MARKET, BY LIBRARY, 2021-2028 (IN $ MILLION)
FIGURE 12: LATIN AMERICA
CRISPR MARKET, BY OTHER PRODUCTS, 2021-2028 (IN $ MILLION)
FIGURE 13: LATIN AMERICA
CRISPR MARKET, BY APPLICATION, 2020 & 2028 (IN %)
FIGURE 14: LATIN AMERICA
CRISPR MARKET, BY GENOME EDITING/GENETIC ENGINEERING, 2021-2028 (IN $ MILLION)
FIGURE 15: LATIN AMERICA
CRISPR MARKET, BY CRISPR PLASMID, 2021-2028 (IN $ MILLION)
FIGURE 16: LATIN AMERICA
CRISPR MARKET, BY HUMAN STEM CELLS, 2021-2028 (IN $ MILLION)
FIGURE 17: LATIN AMERICA
CRISPR MARKET, BY GRNA DATABASE/GENE LIBRARY, 2021-2028 (IN $ MILLION)
FIGURE 18: LATIN AMERICA
CRISPR MARKET, BY CELL LINE ENGINEERING, 2021-2028 (IN $ MILLION)
FIGURE 19: LATIN AMERICA
CRISPR MARKET, BY INDUSTRY VERTICALS, 2020 & 2028 (IN %)
FIGURE 20: LATIN AMERICA
CRISPR MARKET, BY THERAPEUTICS AND DRUG DISCOVERY, 2021-2028 (IN $ MILLION)
FIGURE 21: LATIN AMERICA
CRISPR MARKET, BY BIOLOGICAL RESEARCH, 2021-2028 (IN $ MILLION)
FIGURE 22: LATIN AMERICA
CRISPR MARKET, BY AGRICULTURAL BIOTECH, 2021-2028 (IN $ MILLION)
FIGURE 23: LATIN AMERICA
CRISPR MARKET, BY INDUSTRIAL BIOTECH, 2021-2028 (IN $ MILLION)
FIGURE 24: LATIN AMERICA
CRISPR MARKET, REGIONAL OUTLOOK, 2020 & 2028 (IN %)
FIGURE 25: BRAZIL CRISPR
MARKET 2021-2028 (IN $ MILLION)
FIGURE 26: MEXICO CRISPR
MARKET 2021-2028 (IN $ MILLION)
FIGURE 27: REST OF LATIN
AMERICA CRISPR MARKET 2021-2028 (IN $ MILLION)